Fibroblast-like synoviocytes from the hip and knee have previously been shown to have discrete transcriptomes, epigenetic markers, and JAK-STAT activation patterns, which may mediate the differential clinical responses observed within individual joints in patients with RA receiving tofacitinib [12]. This evidence concerns the gene SOAT1 and rheumatoid arthritis.